Here are three things to know.
1. Aseptic loosening and periprosthetic bacterial infection are the two leading causes of implant failure.
2. The new technology includes a metal implant with hydroxyapatite coating loaded with antibiotics. It is designed to maintain osseointegration while providing sustained antibiotic release to the target area to prevent infection. The implant coating continuously releases the drug up to 180 hours after implantation.
3. Biotech Consortium India Limited acquired the technology.
More articles on surface technology:
DePuy Synthes to promote Fibergraft for spine fusion: 4 insights
Does spine implant coating effect spinal fusion outcomes? — 5 study findings
3 things to know about a surface treatment to reduce implant rejection
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
